Dr Nakagawa of JMA Says Japanese Drug Makers Should Prioritize Domestic Development

Toshio Nakagawa (left) Toshio Nakagawa, vice president of the Japan Medical Association (JMA), called for Japanese drug makers to prioritize drug development in Japan instead of overseas. “Japanese drug makers should develop drugs for people in Japan,” Dr Nakagawa, who...read more